Global Protein Multiplex Assays Market Growth (Status and Outlook) 2023-2029

Global Protein Multiplex Assays Market Growth (Status and Outlook) 2023-2029

Multiplex protein assays allow multiple targets quantification in a single sample, a bit like performing up to 40 different ELISAs in one go. Outsourcing Multiplex Protein Quantification projects to experts may work out more cost effective and time saving. It saves you the hassle of setting up a new technology in your lab, and you can rely on people with years of expertise in the technology to generate quality data on the very first run. Should you wish to set it up in your own lab, some technologies are easily adaptable if you have access to the equipment.

LPI (LP Information)' newest research report, the “Protein Multiplex Assays Industry Forecast” looks at past sales and reviews total world Protein Multiplex Assays sales in 2022, providing a comprehensive analysis by region and market sector of projected Protein Multiplex Assays sales for 2023 through 2029. With Protein Multiplex Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Protein Multiplex Assays industry.

This Insight Report provides a comprehensive analysis of the global Protein Multiplex Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Protein Multiplex Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Protein Multiplex Assays market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Protein Multiplex Assays and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Protein Multiplex Assays.

The global Protein Multiplex Assays market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Protein Multiplex Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Protein Multiplex Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Protein Multiplex Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Protein Multiplex Assays players cover Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abcam, Becton, Dickinson and Company, Merck KGaA and Agilent Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Protein Multiplex Assays market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Planar Protein Assays
Bead-Based Protein Assays
Other Protein Assays

Segmentation by application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.